Hepatitis Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis C Virus Therapy
Research from University of Amsterdam, Department of Medical Microbiology yields new data on hepatitis C virus therapy
July 9th, 2007
A report, "Low-level HCV viraemia after initial response during antiviral therapy: transcription-mediated amplification predicts treatment failure," is newly published data in Antiviral Therapy. According to recent research from Amsterdam, Netherlands, "In chronic hepatitis C patients with an initial virological response (IVR) during antiviral therapy (that is, HCV RNA becomes negative before week 16 of treatment) the significance of reappearing viraemia below the detection limit of PCR is not known. We studied this phenomenon in subsets of patients." "We assessed HCV RNA at weeks 16 and 20 of therapy by PCR and by more sensitive transcription-mediated...
Source: Hepatitis Weekly (2007-07-09)
|
